Sintilimab (IBI 308)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 12:10, 22 April 2022 by Jwarner (talk | contribs) (Jwarner moved page Sintilimab (IBI 308) to Sintilimab (Tyvyt): Approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Sintilimab_(IBI_308)&oldid=55658"